Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines
Open Access
- 1 November 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 20 (11) , 2063-2073
- https://doi.org/10.1093/carcin/20.11.2063
Abstract
There is evidence that reactive oxygen species (ROS) are important mediators of tumor promotion and progression. The molecular mechanisms involved in ROS-mediated signaling, however, are unclear at present. Using ionizing radiation and N -methyl- N ′-nitro- N -nitrosoguanidine (MNNG) as model physical and chemical carcinogens, we have malignantly progressed 308 cells, a papilloma-producing mouse keratinocyte cell line, and investigated the molecular alterations in the progressed phenotypes. In this study, we demonstrate that both MNNG and radiation-progressed malignant variants showed elevated ROS levels that contributed to their proliferative capacity in vitro as well as in vivo . We found increased Erk-1/2 and p38 MAP kinase activities to be important components of ROS-mediated signaling. The pro-oxidant state also contributed to constitutive elevation of AP-1, NFκB and cAMP response element transactivation in the malignant phenotype. Our data provide evidence for a functional role of elevated ROS levels in tumor progression and implicate Erk-1/2 and p38 MAP kinase activation in the malignant progression of mouse keratinocytes.Keywords
This publication has 65 references indexed in Scilit:
- AP-1 function and regulationPublished by Elsevier ,2002
- A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate–induced invasion in mouse keratinocytesMolecular Carcinogenesis, 1997
- PCR/RFLP Assay for Copy Number of Mutant and Wild-Type AllelesBioTechniques, 1996
- c‐jun and multistage carcinogenesis: Association of overexpression of introduced c‐jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter‐induced transformationMolecular Carcinogenesis, 1995
- Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cellsMolecular Carcinogenesis, 1994
- Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.Proceedings of the National Academy of Sciences, 1994
- Multistage carcinogenesis in mouse skinPharmacology & Therapeutics, 1992
- AP1/ jun Function Is Differentially Induced in Promotion-Sensitive and Resistant JB6 CellsScience, 1989
- Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promotersNature, 1983
- The Function and Mechanism of Promoters of CarcinogenesisCRC Critical Reviews in Toxicology, 1973